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Abstract We report here the identification of a human genomic
sequence from the q27.2 region of the X chromosome which
shows a high homology to the L-MYC proto-oncogene. This
sequence is not the MYCL2 homology, previously mapped to the
long arm of the X chromosome at q22-qter by Morton et al., as
we located the MYCL2-processed gene in Xq22-23, using a panel
containing a combination of hybrid DNA carrying different
portions of the human X chromosome. Based on computer
analysis, the MYC-like sequence (MYCL3) is 98.2% identical to
a portion of exon 3 of the MYCL1 gene and maps to the Xq27.2
region, between the DXS312 and DXS292 loci.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
After the completion of the physical map of the entire Xq27
cytogenetic band [1] and the de¢nition of a continuous 12 Mb
YAC contig, we started the assembly of a transcriptional map
by the systematic search for transcription units. In order to
detect functionally transcribed sequences, di¡erent methods
were developed and applied, testing for STSs by retro-tran-
scribed PCR (RT-PCR) on mRNAs from di¡erent tissues,
hybridisation of yeast arti¢cial chromosomes (YACs) to het-
erologous cDNA libraries, Zoo blot analysis for conservation
of sequence fragments between divergent species, cDNA di-
rect selection [2^4], trapping of exons [5], STS virtual mapping
[6] and expressed sequence tag (EST) mapping. By combining
these methods, a number of transcribed sequences have been
identi¢ed providing a functional analysis of this region of the
human genome [7].
Here we report that by using the cDNA direct selection
method with the YAC yWXD340 from Xq27.2 and a combi-
nation of cDNA libraries, we found that a sequence related to
the L-MYC proto-oncogene is located in Xq27.2, a region
associated with neurological disorders [8,9]. However, in spite
of its proximity to a genomic region with high homology to
several ESTs, we were unable to ¢nd evidence of its expres-
sion, suggesting that the L-MYC-like element (denominated
hereafter MYCL3) represents a pseudogene sequence.
2. Materials and methods
2.1. YAC genomic clones, libraries and Southern blot analysis
The YAC yWXD340 used for the cDNA selection is a genomic
clone from the yWXD X3000.11 library [10]. It is located in Xq27.2
and carries the probe DXS292 [1]. Gridded ¢lters containing YACs
speci¢c for the Xq27 chromosomal region were prepared according to
reported procedures [10]. Southern blot analysis was performed as in
Sambrook et al. [11]. Radiolabelling of DNA probes was performed
by random priming [12] using [K-32P]dCTP.
2.2. YAC DNA preparation, linker ligation and biotin DNA fragments
conjugation
Chromosomal DNA preparation of the clone yWXD 340 was car-
ried out in agarose blocks. The YAC was isolated by pulsed ¢eld gel
electrophoresis (PFGE) and excised from the AB1380 host chromo-
somes. Five blocks containing the isolated yWXD340 YAC DNA
were Sau3A (New England Biolabs) digested to completion, the agar-
ose was removed by agarase treatment, as recommended by the man-
ufacturer (Sigma-Aldridge), the DNA was phenol extracted and EtOH
precipitated. The YAC DNA fragments were ligated to adapter A [4]
and ampli¢ed by PCR using a biotin-conjugated oligonucleotide com-
plementary to the same adapter sequence as a polymerisation primer
[4].
2.3. cDNA synthesis
The cDNA selection protocol is basically as described in Pizzuti et
al. [4]. Poly A mRNAs were isolated from di¡erent human tissues and
ds cDNAs were synthesised as described in Maggi et al. [13]. The
cDNAs were ligated to the adapter B and ampli¢ed by PCR using
an oligonucleotide complementary to the adapter B sequence as a
polymerisation primer.
2.4. YAC to cDNA fragments hybridisation
Fragments of digested YAC and cDNAs in a ratio of 1:25 were
mixed, denatured and hybridised for 48 h at 65‡C. The hybridisation
was carried out in 5USSPE, 5UDenhart’s, 0.1% SDS and 10 Wg of
Cot1 human genomic DNA and 5 Wg of yeast DNA were used for
competition. The hybridisation reaction was completed by adding 50
Wl of streptavidin-conjugated magnetic beads (Dynabeads Dynal,
USA).
The bead-biotinylated YAC fragment cDNA complexes were sepa-
rated magnetically and after washing in 0.5USSC at 65‡C for 15 min,
the DNAs were recovered by boiling in water.
The recovered heteroduplex complexes, containing cDNA and ge-
nomic fragments, were ampli¢ed using the oligonucleotide comple-
mentary to the adapter B as a polymerisation primer and cloned
into the pCRII vector (Invitrogen).
2.5. Genomic sequencing and sequence analysis
PCR products were puri¢ed from low melting point agarose gel and
directly sequenced by the dideoxynucleotide chain termination meth-
od using a Perkin Elmer kit. Nucleotide sequence analyses were per-
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formed with the GCG software package. Homology searches were
performed using FastA and BLAST programs.
2.6. Cloning by inverse PCR
The genomic regions at the 5P and 3P ends of the sequence homol-
ogous to the L-MYC were cloned by inverse PCR from the YAC
clone yWXD340 and sequenced. For the 5P end, Pvu II-digested
DNA was diluted and ligated as in Collins and Weissman [14] with
minor modi¢cations. A PCR reaction was then performed with prim-
ers 5R and 3F according to the cycle conditions reported in Table 1.
The 3P end of the region was also obtained by inverse PCR, starting
from Sau3A digested yWXD340 DNA. The PCR reaction was per-
formed with primers 3F and 3R. The PCR ampli¢cation products
were cloned into the pCR2.1 vector (TA cloning kit, Invitrogen).
From the nucleotide sequences generated by inverse PCR, we de-
signed the additional primers pvu57 and 3REV (see Table 1) that
allowed us to amplify the complete sequence we produced.
3. Results
3.1. Isolation of cDNAs hybridising to the Xq27.2 YAC contig
The method used is a hybridisation and PCR-based proto-
col for the isolation of cDNAs encoded by large genomic
fragments [15]. The tissue expression pattern was initially un-
known for the expressed sequence of interest. Therefore we
used a combination of human cDNA libraries including liver,
skeletal muscle, placenta, heart and foetal brain. To perform
our experiments, we decided to work with YACs carrying
evolutionary conserved sequences syntenic to mouse. We
started with the YAC yWXD340 containing the locus
DXS292 that is conserved in mouse X DNA [16,1]. Sau3A
restriction fragments from YAC yWXD340 were incubated
with the before mentioned cDNA libraries as described in
Pizzuti et al. [4]. The cDNAs hybridising to the homologous
YAC fragments were cloned and analysed for the presence of
Xq27-speci¢c transcripts. We focused on inserts ranging from
100 to 350 bp (19 clones out of 48). Two identical membranes
from a sandwich blot containing the ampli¢cation products
were individually hybridised to total human DNA, yeast
AB1380 and pBR322 DNA, respectively, in order to select
clones carrying only human non-repetitive sequences. After
the double hybridisation screening, we selected ¢ve clones
containing non-repetitive human DNA, that were individually
hybridised to gridded ¢lters containing YACs speci¢c for the
Xq27 chromosomal region. One strong signal and four me-
dium/weak signals were obtained by hybridisation of the ¢ve
selected cDNAs.
The strongest signal was detected using cDNA31 that rec-
ognised YAC yWXD340 and other overlapping YACs of the
DXS292 contig. The other four cDNAs that gave weak sig-
nals, when analysed at the sequence level, did not show any
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Table 1
Primers and PCR conditions
Primer name Primer sequence Primer pair Product size (bp) Annealing T*
3IFI CTAGTCTGGGAAAGTCACCC MYCL3 31FI/31RI 191 58‡C
3IRI TGGTTTTCCAGAGCCATATA
np5834 CTCTTTCCCACCTTCCTCCTCAT MYCL3 np5834/31RI 527 60‡C
5FF TTAAAGTTGTTCTGCAACCATGC MYCL3 5FF/3F 2055 60‡C
3F AAGCTGGGGTGGGTAGCGG Genomic
3R AGTCCCAACGGCTCTCCCC (inverse PCR) 3F/3R 590 60‡C
pvu57 CACTGCTTTTTGGACAACATGT MYCL3 pvu57/3REV 2846 60‡C
3REV TATGGCACACAAGACTCTTTTTG Genomic
ILE6 AGCGAGCAGAGATTGAGCCAC MYCL2 ILE6/ILE7 231 62‡C
ILE7 CTATCCTTATGCCAGTACCACA
MYCL2-1 ACCCCCTTCCTCCCACTCTCAATGC MYCL2 MYCL2-1/MYCL2-2 354 60‡C
MYCL2-2 TACAGTTCTCCCTTCTAAGGTGCCT
*For all primer pairs, denaturation and extension temperatures were at 94‡C and 72‡C, respectively. PCR products were detected after 30
ampli¢cation cycles.
Fig. 1. YAC-based physical map of the Xq27.2 region. YACs hy-
bridizing to cDNA31 are indicated by a black ring. The cDNA31 is
located between the DXS312 and the DXS292 loci as shown, since
it hybridizes to yWXD1664 that is part of the DXS292 contig, but
is negative for the DXS292 probe.
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homology with known human or rodent DNA sequences and
are under investigation at present.
Hybridisation of cDNA31 to the Xq27-speci¢c YAC collec-
tion identi¢ed the following YACs: yWXD340, 3191, 1664,
1674, 5336 and 2756-M948H11, all belonging to the DXS292
YAC contig as reported in Zucchi et al. [1] and presented in
Fig. 1 where it is also shown that cDNA31 is located between
DXS312 and DXS292. We excluded the possibility of any
artefact, rearrangement or chromosomal abnormalities attrib-
utable to the FraXA hybrid DNA [17], the source of the
U3000.11 library since cDNA31 also recognised other
YACs, recovered from di¡erent collections of YAC clones
as the CGM library [18], 5Ucell line library [19], ‘F’ library
[20] and CEPH library [21]. Each individual YAC positive for
cDNA31 was EcoRI digested, blotted and hybridised with the
same cDNA31 probe. A single EcoRI hybridisation band of
approximately 4 kb was found on YAC DNA belonging to
the DXS292 contig, no signal was detected in any YACs in-
cluded in the ¢lter as negative controls (data not shown).
3.2. Mapping of the MYC L2 processed gene
cDNA31 (227 bp) was analysed at the sequence level. In its
227 nucleotides (nt), we found a 98.2% identity with the 3P-
untranslated region (UTR) of the MYCL1 gene exon 3, from
nt 6166 to 6392.
A di¡erent MYC-related sequence, the MYC homologous
L2 (MYCL2), was reported by Morton et al. [22] to be
present on the long arm of the X chromosome in the q22-
qter region. Considering the possibility that this MYCL2 se-
quence could be located in Xq27, we designed the primers IL6
and IL7 (see Table 1) in a region of the sequence (a.n. J03069)
published by Morton et al. [22], where the MYCL2 gene di-
verges from MYCL1. Theses primers ampli¢ed a PCR frag-
ment of the expected size (231 bp) from total human DNA
and X only sorted DNA (see Fig. 2 (A, lanes 1 and 3)), as well
as from Ben3B hybrid containing the Xq13-p21 to Xq-ter
region (Fig. 2, B, lane 1). However, no PCR product was
obtained from YAC DNA of the DXS292 contig or
U3000.11 DNA (Fig. 2, A, lanes 7^12 and B, lane 3, respec-
tively).
Consistent with this result is that when we used a PCR
probe, obtained with the primers MYCL2-1 and MYCL2-2
(derived from the exon 3 of the MYCL2 sequence, see Table
1) to hybridise an EcoRI Southern blot, we did not detect any
bands from the U3000.11 DNA (Fig. 3, A, lane 4) while we
obtained a 6.5 kb fragment (corresponding to the MYCL2
FEBS 21711 15-3-99
Fig. 2. A: PCR ampli¢cation using primers the IL6-IL7, speci¢c for the MYC homologous L2. Lanes 1 and 3: total human and X only DNA.
Lanes 2 and 5^12: CHO, YY, Chr7, yWXD340, 1677, 1674, 2756-M948, 1664 and 3191 DNA, respectively. Lane 4: a PCR control containing
no DNA. Lane 4: no template. B: mapping of MYCL2 processed gene. PCR assay was performed using the primers IL6 and IL7 from the
MYCL2 sequence and DNA from di¡erent hybrids. Lane 1: Ben3B hybrid (Xq13-21 to Xqter), lane 2: X only hybrid, lane 3: X3000.11 hybrid
(Xq24-qter), lane 4: no template.
Fig. 3. Hybridization of the MYCL2-derived probe (A) and cDNA31 (B) to EcoRI-digested genomic DNAs. A: A probe generated by primers
MYCL2-1 and MYCL2-2 from the MYCL2 gene was hybridized to the following DNA: lanes 1^6: CHO, total human, X only, U3000.11, to-
tal human and 5UDNA, respectively. The U3000.11 DNA (lane 4) does not hybridize to the MYCL2-derived probe. B: Hybridization of the
cDNA31 to the same blot. Total human (lanes 2 and 5), 5UDNA (lane 6), X only DNA (lane 3), U3000.11 DNA (lane 4). For both ¢gures
no hybridization signal was detected for CHO DNA (lane 1). Samples were loaded with the purpose of having the same amount of XDNA.
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gene where no EcoRI sites are detected) from total human
DNA (lanes 2 and 5) and DNA from X only (lane 3)and
the 5Ucell line (lane 6). In addition, a band of approximately
10.5 kb, attributable to the MYCL1 gene, was detected on
total human DNA (lanes 2 and 5).
Conversely, when we hybridised the cDNA31 probe to the
same membrane blot, one band of approximately 4 kb was
detected on U3000.11 DNA (Fig. 3, B, lane 4) on total hu-
man DNA (lanes 2 and 5), 5U (lane 6, CTR) and X only
DNA (lane 3). In addition to the 6.5 kb MYCL2 fragment, a
band of 5.5 kb was found in all the DNA analysed with the
exception of the U3000 DNA (lane 4). Considering that the
cDNA31 probe, used in this hybridisation, encompasses the
last portion of the published MYCL2 sequence, we assume
this band due to its hybridisation to the next EcoRI fragment.
In both cases, under this stringency, EcoRI digested hamster
DNA (lane 1) did not show any hybridisation signal.
Taking all the results together, we can conclude that the
processed MYCL2 maps to the long arm of the X chromo-
some at the band q22-23 and it is therefore distinct from the
sequence found on Xq27. During our last search in databases
before the submission of the paper, we found that a PAC
clone (dj320j15) from the Xq22-23 region shows sequence ho-
mology with the MYCL2 gene, con¢rming that our sequence,
MYCL3, is distinct from both MYCL1 and MYCL2 genes.
3.3. Genomic sequencing and sequence analysis
In order to determine the degree of homology between the
selected cDNA31 and the corresponding genomic sequence,
we sequenced its genomic counterpart. By using primers
31F1 and 31R1 (reported in Table 1) designed at the 3P and
5P ends of the cDNA sequence, we obtained a unique PCR
fragment of the expected size using U3000.11 or yWXD340
DNA (Fig. 4).
From the sequence analysis of the PCR product generated
from the YAC340 with these primers, we found that a high
degree of homology (93.9%) is maintained between the X
DNA and exon 3 of the MYCL1 gene. The additional primer
np5834 designed from the MYCL1 sequence at the 5P of the
primer 31FI, when used in combination with primer 31RI,
produced a PCR fragment of the correct size that, by sequenc-
ing, proved to maintain the MYCL1 homology.
From this region, homologous to the MYCL1 gene, we
extended the sequence by cloning fragments via inverse PCR
at the 3P and the 5P ends using the YAC yWXD340 as a
template.
At the 3P end, we cloned and sequenced 483 nt, the prox-
imal 446 of which are 91.5% homologous to MYCL1. The
remaining 37 nt were without homology with any sequence
in the databases. At the 5P end, we extended the sequence of
2114 nt, the ¢rst 458 nt with 90.4% sequence homology of
with MYCL1. Then the homology with the MYCL1 gene is
interrupted. Computer analysis of the remaining 1656 nt
showed that the region between nt 1227 and 1492 bears sig-
ni¢cant homology to several ESTs (62.2^91.2% homology in
17 ESTs) which is not related to known repetitive sequences.
However no ORFs with similarity to any protein in any data-
base were detected through computer analysis. In addition,
attempts to amplify RT-PCR products, using primers de-
signed in this region of the EST homology combined with
others in the MYCL3 sequence, were always negative. North-
ern blots containing mRNAs from di¡erent foetal and adult
human tissues were also hybridised with our sequence, but the
bands obtained were compatible with those pertaining to the
MYC family members already described. The sequence we
produced (2824 nt) is available in the database (an Y16968).
The region between nt 1657 and 2787 is homologous to the
MYCL1 gene (nt 5681 and 6814) corresponding to the 3P
UTR of exon 3. A comparative analysis of the MYC-related
sequence found in Xq27.2 revealed that it is characterised by
AU-rich regions that are considered to confer selective
mRNA instability [23]. A consensus sequence (AUUUA), typ-
ical of a number of short-lived mRNAs [24], has been recog-
nised at position 2674 and 2710. The presence of a 14 nt direct
repeat (AAGAGTCTTGTGTG), occurring at nt 1642 and
2806 on the Xq27.2 MYC-related sequence and £anking the
region of homology to the MYCL1 gene, has also been iden-
ti¢ed. This motifs may be related to the mechanism respon-
sible for sequence reintegration in the genome [25].
4. Discussion
After having completed the Xq27 physical map, we focused
on speci¢c regions of the Xq27 band to start identifying genes.
We chose YACs carrying human DXS probes conserved in
mouse DNA and we focused on subregions of the q27 band
having a high GC content [26] in order to maximise the pos-
sibility of ¢nding genes.
We present here the ¢nding of a sequence related to the
MYCL1 proto-oncogene, selected from cDNAs obtained
from di¡erent tissues, using the cDNA direct selection ap-
proach [15]. We excluded the possibility that the MYCL3
sequence was the MYC homologous L2 previously mapped
to the long arm of the X chromosome in q22-qter by Morton
et al. [22], as we located it in Xq22-23 by using a panel con-
taining a combination of DNAs from hybrids carrying di¡er-
ent portions of the human X chromosome. Other sequences
have been identi¢ed with comparable homology to some por-
tions of C-MYC and they represent pseudogenes [25] or trun-
cated genes as B-MYC [27] or S-MYC [28], whose functions
remain unknown. The existence of a region homologous to
several ESTs just upstream of the MYCL3 sequence raises the
possibility that this sequence has been transposed at the 3P
end of an active gene, to which it could confer new properties
as has been described for the urokinase gene 3P UTR region,
containing sequences that can exert both positive and negative
in£uences on the expression of chimeric reporter genes [29].
However, we were unable to ¢nd any evidence of MYCL3
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Fig. 4. PCR ampli¢cation products obtained using primers from the
MYCL3 sequence. PCR product from the cDNA31 (lane 1, positive
control), U3000.11 (lane 2), total human (lane 3), CHO (lane 4),
yeast (lane 5, negative control) DNA. Lanes 6^8: yWXD340, 3191
and 1674 YAC DNA. Lane 9: PCR control containing no DNA.
M: marker DNA.
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transcription, neither by RT-PCR nor by Northern analysis.
Taking these results together, it is very likely that the MYCL3
sequence detected in Xq27.2 represents another member of the
MYC-related pseudogene family.
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